FR3059236B1 - Extraits de plantes du genre tagetes et leurs utilisations - Google Patents

Extraits de plantes du genre tagetes et leurs utilisations Download PDF

Info

Publication number
FR3059236B1
FR3059236B1 FR1661486A FR1661486A FR3059236B1 FR 3059236 B1 FR3059236 B1 FR 3059236B1 FR 1661486 A FR1661486 A FR 1661486A FR 1661486 A FR1661486 A FR 1661486A FR 3059236 B1 FR3059236 B1 FR 3059236B1
Authority
FR
France
Prior art keywords
plants
extract
genus tagetes
extracts
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1661486A
Other languages
English (en)
Other versions
FR3059236A1 (fr
Inventor
Jean-Francois Ginglinger
Simon Deslis
Lena Emile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plant Advanced Technologies PAT SAS
Original Assignee
Plant Advanced Technologies PAT SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plant Advanced Technologies PAT SAS filed Critical Plant Advanced Technologies PAT SAS
Priority to FR1661486A priority Critical patent/FR3059236B1/fr
Priority to PCT/EP2017/080224 priority patent/WO2018096039A1/fr
Priority to US16/463,956 priority patent/US20200375880A1/en
Publication of FR3059236A1 publication Critical patent/FR3059236A1/fr
Application granted granted Critical
Publication of FR3059236B1 publication Critical patent/FR3059236B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G22/00—Cultivation of specific crops or plants not otherwise provided for
    • A01G22/60—Flowers; Ornamental plants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G31/00—Soilless cultivation, e.g. hydroponics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Environmental Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne un extrait de plantes du genre Tagetes enrichi en acide léontopodique B, un procédé de préparation d'un tel extrait ainsi qu'une composition cosmétique et une composition nutraceutique et une composition pharmaceutique, lesdites compositions comprenant en tant qu'agent actif au moins un extrait de plantes du genre Tagetes selon l'invention. L'invention a également pour objet l'utilisation d'un extrait selon l'invention, notamment en tant que médicament pour la prévention et/ou le traitement d'une maladie neurodégénérative, en particulier la maladie d'Alzheimer ; mais également une composition cosmétique comprenant un extrait selon l'invention.
FR1661486A 2016-11-25 2016-11-25 Extraits de plantes du genre tagetes et leurs utilisations Expired - Fee Related FR3059236B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1661486A FR3059236B1 (fr) 2016-11-25 2016-11-25 Extraits de plantes du genre tagetes et leurs utilisations
PCT/EP2017/080224 WO2018096039A1 (fr) 2016-11-25 2017-11-23 Extraits de plantes du genre tagetes et leurs utilisations
US16/463,956 US20200375880A1 (en) 2016-11-25 2017-11-23 Plant extracts from the tagetes genus and uses of same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1661486 2016-11-25
FR1661486A FR3059236B1 (fr) 2016-11-25 2016-11-25 Extraits de plantes du genre tagetes et leurs utilisations

Publications (2)

Publication Number Publication Date
FR3059236A1 FR3059236A1 (fr) 2018-06-01
FR3059236B1 true FR3059236B1 (fr) 2019-05-17

Family

ID=58010001

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1661486A Expired - Fee Related FR3059236B1 (fr) 2016-11-25 2016-11-25 Extraits de plantes du genre tagetes et leurs utilisations

Country Status (3)

Country Link
US (1) US20200375880A1 (fr)
FR (1) FR3059236B1 (fr)
WO (1) WO2018096039A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL241271B1 (pl) 2019-05-31 2022-08-29 Inst Badawczy Innowacyjno Rozwojowy Biotomed Spolka Z Ograniczona Odpowiedzialnoscia Połączenie związku typu triterpenu lupanu do zapobiegania i leczenia choroby Alzheimera
CN111393297A (zh) * 2020-02-21 2020-07-10 湖南中茂生物科技有限公司 一种从洋蓟叶中提取洋蓟酸的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2800740B1 (fr) 1999-11-08 2002-10-11 Lorraine Inst Nat Polytech Procede de production de metabolites a partir de vegetaux en culture hors sol
EP2239334A1 (fr) 2003-05-06 2010-10-13 E. I. du Pont de Nemours and Company Purification de propanédiols 1,3 produits biologiquement
CN101856347B (zh) * 2009-04-08 2013-10-23 伍义行 火绒草属植物提取物及其活性成分在治疗肝炎中的用途

Also Published As

Publication number Publication date
WO2018096039A1 (fr) 2018-05-31
US20200375880A1 (en) 2020-12-03
FR3059236A1 (fr) 2018-06-01

Similar Documents

Publication Publication Date Title
MA40290A1 (fr) Agents immunorégulateurs
MA39225A1 (fr) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tétrahydropyridines utilisées en tant qu'inhibiteurs de bace1 dans le traitement de la maladie d'alzheimer
MA40768A (fr) Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue
MA49628B1 (fr) Processus pour la purification de l'acide hyaluronique
FR2949044B1 (fr) Composition comprenant une fraction d'insaponifiable
MA33299B1 (fr) Nouvelle formulation de naproxène
MA33295B1 (fr) Nouvelle formulation de diclofénac
MA40769A (fr) Indoles mono ou di-substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
FR3058059B1 (fr) Composition pharmaceutique comprenant le beta-elemene, le lupeol et le 2-hydroxycinnamaldehyde et/ou le 2'-benzoyloxycinnalmaldehyde et/ou le beta-sitosterol et/ou la curcumine.
FR3053253B1 (fr) Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique
MA40283A (fr) Aptamères spécifiques du récepteur tlr-4 et leurs utilisations
MA37763A1 (fr) Difluoro-hexahydro-cyclopentaoxazinyles et difluoro-hexahydro-benzooxazinyles en tant qu'inhibiteurs de bace1
FR3075642B1 (fr) Extrait de fleurs de kapokier et compositions cosmetiques, pharmaceutiques ou dermatologiques le comprenant
FR3059236B1 (fr) Extraits de plantes du genre tagetes et leurs utilisations
MA34090B1 (fr) Composition pharmaceutique stabilisée
MA47082B1 (fr) Amides aromatiques d'acide carboxylique en tant qu'antagonistes des recepteurs bradykinin b1
JP2016513650A5 (fr)
NZ760781A (en) Process for the preparation of standardized composition of arjunoglucoside from the bark of terminalia arjuna
FR2952372B1 (fr) Nouveaux derives de mannopyranoside ayant une activite anticancereuse
FR3059550B1 (fr) Traitement des troubles causes par l'alcoolisation foetale (tcaf)
MA39406A1 (fr) Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline
MA61742A1 (fr) Composition pharmaceutique aqueuse d'anticorps anti pd-1 prolgolimab et son utilisation
MA58507A1 (fr) Composition pharmaceutique aqueuse de levilimab
PH12020551470A1 (en) Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
MA41102A (fr) Compositions contenant de la curcumine à biodisponibilité améliorée

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180601

CA Change of address

Effective date: 20180919

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20230705